Tamper evidence, a requirement against counterfeiting
Directive 2011/62 lays down rules to ensure at all times the authentication of medicinal products and their monitoring throughout the supply chain, which entails a series of measures to be applied by the different actors involved in the production and marketing of medicines.
17 Nov 16
